Meeting the needs of those who need it most
HEMA Biologics is a privately held biopharmaceutical company focused on the rarest bleeding disorders. We aspire to support patients living with these disorders, partner with the broader community that cares for them, and bring meaningful treatments and services to help better their daily lives.
We take our mission seriously
We believe that our focused approach can help advance our mission to improve the health and care for people living with the rarest bleeding disorders. We are committed to:
Rooted in Europe, making a difference in the US
We take pride in the heritage of LFB SA, a French state-owned company and the developer and manufacturer of our investigational treatments.
LFB SA is an innovative European biopharmaceutical company dedicated to the development, manufacture, and safety of therapeutic proteins.
HEMA Biologics is excited to partner with LFB SA in the further development and potential commercialization of these treatments in the United States.
Sign up to learn more about our focus on the rarest bleeding disorder community